Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (3-(2-dimethylamino)ethyl)indol-4-ol
2. Psilocin Hydrochloride
3. Psilocin Tartrate (1:1)
1. Psilocine
2. 4-hydroxy-n,n-dimethyltryptamine
3. 520-53-6
4. Psilotsin
5. Psilocyn
6. 3-[2-(dimethylamino)ethyl]-1h-indol-4-ol
7. 3-(2-(dimethylamino)ethyl)indol-4-ol
8. N,n-dimethyl-4-hydroxytryptamine
9. 3-(2-(dimethylamino)ethyl)-1h-indol-4-ol
10. Cms88kuw0g
11. 4-ho-dmt
12. Chembl65547
13. Chebi:8613
14. Ncgc00247728-01
15. 1h-indol-4-ol, 3-[2-(dimethylamino)ethyl]-
16. 3-[2-(dimethylamino)ethyl]-1~{h}-indol-4-ol
17. Indol-4-ol, 3-(2-(dimethylamino)ethyl)-
18. Indol-4-ol, 3-[2-(dimethylamino)ethyl]-
19. Cx-59
20. Einecs 208-296-5
21. Unii-cms88kuw0g
22. Brn 0160503
23. Dea No. 7438
24. 91q
25. Psilocin [mi]
26. Psilocin [mart.]
27. Psilocin [who-dd]
28. 4-oh-dmt
29. Magic Mushrooms (salt/mix)
30. Dsstox_cid_28825
31. Dsstox_rid_83094
32. Dsstox_gsid_48899
33. 5-22-12-00014 (beilstein Handbook Reference)
34. Schembl194899
35. Psilocin/psilocybin (salt/mix)
36. Zinc2001
37. Dtxsid5048899
38. Gtpl11291
39. Spciygntamctro-uhfffaoysa-
40. Cx 59
41. Tox21_112894
42. Bdbm50081701
43. Akos022505992
44. En-0002
45. 3-[2-(dimethylamino)ethyl]-indol-4-ol
46. Cas-520-53-6
47. 3-[2-(dimethylamino)ethyl]-1h-indol-4-ol #
48. C08312
49. P-7800
50. 4-hydroxy-n,n-dimethyltryptamine Psilocin
51. L000675
52. Q409150
53. Psilocin, Vial Of 5 Mg, Certified Reference Material
54. Psilocin Solution, 100 Mug/ml In Methanol, Drug Standard
55. Psilocin Solution, 1.0 Mg/ml In Acetonitrile, Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 204.27 g/mol |
---|---|
Molecular Formula | C12H16N2O |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 204.126263138 g/mol |
Monoisotopic Mass | 204.126263138 g/mol |
Topological Polar Surface Area | 39.3 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 208 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Hallucinogens
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)
Psilocin has known human metabolites that include (2S,3S,4S,5R)-6-[[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Market Place
ABOUT THIS PAGE
A Psilocin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Psilocin, including repackagers and relabelers. The FDA regulates Psilocin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Psilocin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Psilocin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Psilocin supplier is an individual or a company that provides Psilocin active pharmaceutical ingredient (API) or Psilocin finished formulations upon request. The Psilocin suppliers may include Psilocin API manufacturers, exporters, distributors and traders.
click here to find a list of Psilocin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Psilocin DMF (Drug Master File) is a document detailing the whole manufacturing process of Psilocin active pharmaceutical ingredient (API) in detail. Different forms of Psilocin DMFs exist exist since differing nations have different regulations, such as Psilocin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Psilocin DMF submitted to regulatory agencies in the US is known as a USDMF. Psilocin USDMF includes data on Psilocin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Psilocin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Psilocin suppliers with USDMF on PharmaCompass.
Psilocin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Psilocin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Psilocin GMP manufacturer or Psilocin GMP API supplier for your needs.
A Psilocin CoA (Certificate of Analysis) is a formal document that attests to Psilocin's compliance with Psilocin specifications and serves as a tool for batch-level quality control.
Psilocin CoA mostly includes findings from lab analyses of a specific batch. For each Psilocin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Psilocin may be tested according to a variety of international standards, such as European Pharmacopoeia (Psilocin EP), Psilocin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Psilocin USP).
LOOKING FOR A SUPPLIER?